Titre : Korarchaeota

Korarchaeota : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Korarchaeota : Questions médicales les plus fréquentes", "headline": "Korarchaeota : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Korarchaeota : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-04", "dateModified": "2025-04-29", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Korarchaeota" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Archéobactéries", "url": "https://questionsmedicales.fr/mesh/D001105", "about": { "@type": "MedicalCondition", "name": "Archéobactéries", "code": { "@type": "MedicalCode", "code": "D001105", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B02" } } }, "about": { "@type": "MedicalCondition", "name": "Korarchaeota", "alternateName": "Korarchaeota", "code": { "@type": "MedicalCode", "code": "D019708", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Luke J McKay", "url": "https://questionsmedicales.fr/author/Luke%20J%20McKay", "affiliation": { "@type": "Organization", "name": "Department of Land Resources and Environmental Sciences, Montana State University, Bozeman, MT, USA. luke.mckay@montana.edu." } }, { "@type": "Person", "name": "Mensur Dlakić", "url": "https://questionsmedicales.fr/author/Mensur%20Dlaki%C4%87", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Immunology, Montana State University, Bozeman, MT, USA." } }, { "@type": "Person", "name": "Matthew W Fields", "url": "https://questionsmedicales.fr/author/Matthew%20W%20Fields", "affiliation": { "@type": "Organization", "name": "Center for Biofilm Engineering, Montana State University, Bozeman, MT, USA." } }, { "@type": "Person", "name": "Tom O Delmont", "url": "https://questionsmedicales.fr/author/Tom%20O%20Delmont", "affiliation": { "@type": "Organization", "name": "Department of Medicine, University of Chicago, Chicago, IL, USA." } }, { "@type": "Person", "name": "A Murat Eren", "url": "https://questionsmedicales.fr/author/A%20Murat%20Eren", "affiliation": { "@type": "Organization", "name": "Department of Medicine, University of Chicago, Chicago, IL, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The role of diffusion magnetic resonance imaging in determining tumor aggressiveness during preoperative surgical planning in early-stage endometrial cancer.", "datePublished": "2023-04-04", "url": "https://questionsmedicales.fr/article/37014376", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00117-023-01134-7" } }, { "@type": "ScholarlyArticle", "name": "Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: A prospective cohort study.", "datePublished": "2023-03-23", "url": "https://questionsmedicales.fr/article/36952375", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.5791" } }, { "@type": "ScholarlyArticle", "name": "Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment.", "datePublished": "2023-02-06", "url": "https://questionsmedicales.fr/article/36814908", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2023.1073550" } }, { "@type": "ScholarlyArticle", "name": "Meta-analysis of laparoscopic radical hysterectomy, excluding robotic assisted versus open radical hysterectomy for early stage cervical cancer.", "datePublished": "2023-01-06", "url": "https://questionsmedicales.fr/article/36609438", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-27430-9" } }, { "@type": "ScholarlyArticle", "name": "Feasibility of a lung airway navigation system using fiber-Bragg shape sensing and artificial intelligence for early diagnosis of lung cancer.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36476838", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0277938" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Archéobactéries", "item": "https://questionsmedicales.fr/mesh/D001105" }, { "@type": "ListItem", "position": 3, "name": "Korarchaeota", "item": "https://questionsmedicales.fr/mesh/D019708" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Korarchaeota - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Korarchaeota", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Korarchaeota", "description": "Comment identifier les Korarchaeota dans un échantillon ?\nQuels tests sont utilisés pour détecter les Korarchaeota ?\nLes Korarchaeota peuvent-elles être cultivées en laboratoire ?\nQuels milieux favorisent la croissance des Korarchaeota ?\nY a-t-il des marqueurs spécifiques pour les Korarchaeota ?", "url": "https://questionsmedicales.fr/mesh/D019708?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Korarchaeota", "description": "Quels symptômes sont associés aux infections par Korarchaeota ?\nLes Korarchaeota provoquent-elles des maladies humaines ?\nPeut-on observer des symptômes chez d'autres organismes ?\nLes Korarchaeota sont-elles liées à des maladies ?\nComment les Korarchaeota affectent-elles leur environnement ?", "url": "https://questionsmedicales.fr/mesh/D019708?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Korarchaeota", "description": "Comment prévenir les infections par Korarchaeota ?\nLes Korarchaeota sont-elles dangereuses pour l'homme ?\nComment éviter la contamination par des archées ?\nLes Korarchaeota peuvent-elles affecter la santé des écosystèmes ?\nY a-t-il des mesures de sécurité en laboratoire ?", "url": "https://questionsmedicales.fr/mesh/D019708?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Korarchaeota", "description": "Y a-t-il des traitements pour les infections par Korarchaeota ?\nComment les Korarchaeota sont-elles utilisées en biotechnologie ?\nLes Korarchaeota peuvent-elles être utilisées en médecine ?\nQuels avantages les Korarchaeota offrent-elles en recherche ?\nPeut-on exploiter les Korarchaeota pour des biocarburants ?", "url": "https://questionsmedicales.fr/mesh/D019708?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Korarchaeota", "description": "Quelles complications peuvent survenir avec les Korarchaeota ?\nLes Korarchaeota peuvent-elles causer des déséquilibres écologiques ?\nY a-t-il des risques liés à l'étude des Korarchaeota ?\nLes Korarchaeota peuvent-elles interagir avec d'autres micro-organismes ?\nLes Korarchaeota sont-elles résistantes aux antibiotiques ?", "url": "https://questionsmedicales.fr/mesh/D019708?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Korarchaeota", "description": "Quels facteurs favorisent la présence des Korarchaeota ?\nLes Korarchaeota sont-elles sensibles aux changements environnementaux ?\nQuels habitats sont propices aux Korarchaeota ?\nLes Korarchaeota sont-elles affectées par la pollution ?\nY a-t-il des conditions spécifiques pour les Korarchaeota ?", "url": "https://questionsmedicales.fr/mesh/D019708?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les Korarchaeota dans un échantillon ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par séquençage de l'ADN et techniques de culture spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les Korarchaeota ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de PCR et des analyses phylogénétiques sont couramment utilisés." } }, { "@type": "Question", "name": "Les Korarchaeota peuvent-elles être cultivées en laboratoire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont difficiles à cultiver, nécessitant des conditions spécifiques de chaleur et de pH." } }, { "@type": "Question", "name": "Quels milieux favorisent la croissance des Korarchaeota ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elles prospèrent dans des milieux riches en chaleur, comme les sources hydrothermales." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour les Korarchaeota ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des gènes spécifiques, comme ceux de la méthanogenèse, peuvent servir de marqueurs." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux infections par Korarchaeota ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les Korarchaeota ne sont pas pathogènes pour l'homme, donc pas de symptômes associés." } }, { "@type": "Question", "name": "Les Korarchaeota provoquent-elles des maladies humaines ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles sont principalement étudiées dans des contextes environnementaux et non pathogènes." } }, { "@type": "Question", "name": "Peut-on observer des symptômes chez d'autres organismes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent influencer des écosystèmes, mais ne causent pas de symptômes directs." } }, { "@type": "Question", "name": "Les Korarchaeota sont-elles liées à des maladies ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, aucune association avec des maladies humaines n'est établie." } }, { "@type": "Question", "name": "Comment les Korarchaeota affectent-elles leur environnement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elles jouent un rôle dans le cycle des nutriments et la décomposition dans les milieux extrêmes." } }, { "@type": "Question", "name": "Comment prévenir les infections par Korarchaeota ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Aucune prévention n'est nécessaire, car elles ne causent pas d'infections chez l'homme." } }, { "@type": "Question", "name": "Les Korarchaeota sont-elles dangereuses pour l'homme ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles ne sont pas considérées comme dangereuses ou pathogènes pour l'homme." } }, { "@type": "Question", "name": "Comment éviter la contamination par des archées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les environnements extrêmes où elles prospèrent, comme les sources chaudes." } }, { "@type": "Question", "name": "Les Korarchaeota peuvent-elles affecter la santé des écosystèmes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Elles jouent un rôle crucial dans les écosystèmes extrêmes, mais ne nuisent pas à la santé humaine." } }, { "@type": "Question", "name": "Y a-t-il des mesures de sécurité en laboratoire ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des protocoles de sécurité standard sont appliqués lors de la manipulation d'archées en laboratoire." } }, { "@type": "Question", "name": "Y a-t-il des traitements pour les infections par Korarchaeota ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Aucun traitement n'est nécessaire, car elles ne sont pas pathogènes pour l'homme." } }, { "@type": "Question", "name": "Comment les Korarchaeota sont-elles utilisées en biotechnologie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont étudiées pour leurs enzymes thermophiles, utiles dans divers processus industriels." } }, { "@type": "Question", "name": "Les Korarchaeota peuvent-elles être utilisées en médecine ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont pas utilisées en médecine, mais leur étude peut inspirer des innovations." } }, { "@type": "Question", "name": "Quels avantages les Korarchaeota offrent-elles en recherche ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elles aident à comprendre l'évolution des archées et leur rôle dans les écosystèmes extrêmes." } }, { "@type": "Question", "name": "Peut-on exploiter les Korarchaeota pour des biocarburants ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont étudiées pour leur potentiel dans la production de biocarburants à partir de biomasse." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les Korarchaeota ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Aucune complication n'est associée aux Korarchaeota, car elles ne sont pas pathogènes." } }, { "@type": "Question", "name": "Les Korarchaeota peuvent-elles causer des déséquilibres écologiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent influencer les écosystèmes, mais ne causent pas de déséquilibres notables." } }, { "@type": "Question", "name": "Y a-t-il des risques liés à l'étude des Korarchaeota ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les risques sont minimes, mais des précautions doivent être prises lors de la manipulation." } }, { "@type": "Question", "name": "Les Korarchaeota peuvent-elles interagir avec d'autres micro-organismes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent interagir avec d'autres archées et bactéries dans leur habitat." } }, { "@type": "Question", "name": "Les Korarchaeota sont-elles résistantes aux antibiotiques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont pas testées pour la résistance aux antibiotiques, car elles ne sont pas pathogènes." } }, { "@type": "Question", "name": "Quels facteurs favorisent la présence des Korarchaeota ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Elles se trouvent dans des environnements extrêmes, comme les sources chaudes et les geysers." } }, { "@type": "Question", "name": "Les Korarchaeota sont-elles sensibles aux changements environnementaux ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont adaptées aux conditions extrêmes, mais peuvent être affectées par des changements rapides." } }, { "@type": "Question", "name": "Quels habitats sont propices aux Korarchaeota ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les habitats géothermiques, comme les sources chaudes, sont idéaux pour leur croissance." } }, { "@type": "Question", "name": "Les Korarchaeota sont-elles affectées par la pollution ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être sensibles à la pollution, mais prospèrent généralement dans des milieux extrêmes." } }, { "@type": "Question", "name": "Y a-t-il des conditions spécifiques pour les Korarchaeota ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Elles nécessitent des températures élevées et des niveaux de pH spécifiques pour croître." } } ] } ] }

Sources (10000 au total)

The role of diffusion magnetic resonance imaging in determining tumor aggressiveness during preoperative surgical planning in early-stage endometrial cancer.

The present study aimed to evaluate the relationship between tumor volume and apparent diffusion coefficient (ADC) in preoperative magnetic resonance imaging and deep myometrial invasion, tumor grade,... The study included 73 patients diagnosed with early-stage endometrial cancer based on histopathological examination between May 2014 and July 2019. Receiver operating characteristic (ROC) curve analys... The areas under the ROC curves (AUCs) of ADC and tumor volume in predicting LVI, DMI, and high tumor grade were significantly greater than those for superficial myometrial invasion and low-grade tumor... In the absence of pathological pelvic lymph nodes in early-stage endometrial cancer, tumor volume in DWI sequences determines the active tumor load and tumor aggressiveness. Furthermore, a low ADC ind...

Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: A prospective cohort study.

Although early diagnosis and surgical resection of the tumor have been shown to be the most important predictors of lung cancer survival, long-term survival for surgically-resected early-stage lung ca... In this prospective study we aimed to investigate the survival and prognostic factors of surgically-resected early-stage non-small cell lung cancer (NSCLC) in Central and Eastern Europe.... We recruited 2052 patients with stage I-IIIA NSCLC from 9 centers in Russia, Poland, Serbia, Czech Republic, and Romania, between 2007-2016 and followed them annually through 2020.... During follow-up, there were 1121 deaths (including 730 cancer-specific deaths). Median survival time was 4.9 years, and the 5-year overall survival was 49.5%. In the multivariable model, mortality wa... This study shows that the 5-year survival rate of surgically-resected stage I-IIIA NSCLC is still around 50% in Central and Eastern Europe. In addition to non-modifiable prognostic factors, lifetime p...

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment.

Currently, targeting immune checkpoint molecules holds great promise for triple-negative breast cancer (TNBC). However, the expression landscape of immune checkpoint genes (ICGs) in TNBC remains large... Herein, we systematically investigated the ICGs expression patterns in 422 TNBC samples. We evaluated the ICGs molecular typing based on the ICGs expression profile and explored the associations betwe... Two ICGs clusters and two ICGs-related gene clusters were determined, which were involved in different survival outcomes, biological roles and infiltration levels of immune cells. We established a qua... Collectively, dissecting the ICGs expression patterns not only provides a new insight into TNBC subtypes but also deepens the understanding of ICGs in the tumor immune microenvironment....

Meta-analysis of laparoscopic radical hysterectomy, excluding robotic assisted versus open radical hysterectomy for early stage cervical cancer.

Recent evidence has shown an increase in recurrence and a decrease in overall survival in patients treated with laparoscopic radical hysterectomy (LRH) and robotic assisted radical hysterectomy (RRH) ...

Initial Experience With Trans-anal Minimally Invasive Surgery (TAMIS) for Rectal Polyps and Early Colorectal Cancers at Cumberland Infirmary, Carlisle.

Bowel cancer is the fourth most common type of cancer in the United Kingdom in 2019. Total mesorectal excision is the standard procedure for the removal of rectal tumors, however, it comes with seriou... During a five-year period, 42 patients underwent TAMIS at Cumberland Infirmary. The primary indication for TAMIS was distal rectal lesions, large rectal polyps up to 120 mm, and early rectal cancer (T... Our findings suggest that TAMIS produces positive results. The size of the lesions removed, and the effect of an early learning curve are reflected in the rate of specimen fragmentation and polyp recu...

Ultrasound contrast-enhanced patterns of sentinel lymph nodes: predictive value for nodal status and metastatic burden in early breast cancer.

In the post-Z0011 era, sentinel lymph node (SLN) status and metastatic burden determine whether axillary management entails conservative sentinel lymph node biopsy (SLNB) or radical axillary lymph nod... A retrospective study was conducted on 88 consecutive patients who were diagnosed with clinical T1-2N0 breast cancer between December 2020 and November 2021 at the Lanzhou University Second Hospital a... CEUS successfully identified at least 1 SLN in 88 patients, with a total of 118 SLNs identified in the entire cohort. Univariate analysis showed that lesion size, blood flow grade, SLN longitudinal di... The contrast-enhanced pattern of the SLN is an independent risk factor for SLN status. Patients presenting with a type I or type II SLN enhanced pattern are unlikely to have high-burden metastases det...

Uniportal robotic-assisted thoracoscopic surgery for early-stage lung cancer with the Da Vinci Xi: Initial experience of two cases.

Minimally invasive surgery (MIS) techniques, currently considered the gold standard in the treatment of early-stage non-small cell lung cancer (NSCLC), are mainly represented by video-assisted thoraco... U-RATS was conducted through a single 4 cm long antero-lateral mini-thoracotomy (ALMT) in the sixth intercostal space at the mid-axillary line. Three 8 mm robotic trocars were positioned and connected... Case 1: an 82-year-old woman (American Society of Anaesthesiologists [ASA III]) underwent a left S6 segmentectomy for a clinical stage IA2 NSCLC, complicated by an air leak that resolved spontaneously... From what emerged in our small series, U-RATS with the Da Vinci Xi surgical system might be considered a safe, reliable, and effective alternative to other MIS techniques. Larger prospective studies a...